Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Hyperinsulinemia in Non-Alcoholic Fatty Liver Disease (NAFLD) Pathogenesis: Diazoxide Pilot & Feasibility Study

NCT05729282 is registered in ClinicalTrials.gov with Columbia University as lead sponsor.

NCT NCT05729282
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05729282 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Hyperinsulinemia in Non-Alcoholic Fatty Liver Disease (NAFLD) Pathogenesis: Diazoxide Pilot & Feasibility Study
Lead sponsor
Columbia University
Phase
Phase 1
Overall status
Completed
Start date
August 1, 2023
Completion date
September 10, 2025
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hyperinsulinemia, insulin resistance, non-alcoholic fatty liver disease, prediabetic state